Human papilloma virus and p53 in head and neck cancer: Clinical correlates and survival

Clinical Cancer Research

Volumn 2, Issue 4, 1996, Pages 755-762

  Haraf, Daniel J ^a   Nodzenski, Edwardine ^a   Brachman, David ^a   Mick, Rosemarie ^a   Montag, Anthony ^a   Graves, Deborah ^a   Vokes, Everett E ^a   Weichselbaum, Ralph R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; PROTEIN P53;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENE MUTATION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TONSIL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SURVIVAL RATE; TUMOR VIRUS INFECTIONS;

EID: 0029947497     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Boring, C. C., Squires, T. S., Tong, T., and Montgomery, S. Cancer statistics, 1994. CA Cancer J. Clin., 44: 7-26, 1994.
2. Vokes, E. E., Weichselbaum, R. R., Lipman, S. M., and Hong, W. K. Head and neck cancer. N. Engl. J. Med., 328: 184-194, 1993.
3. Pinborg, J. J. Control of oral cancer in developing countries. Bull. WHO, 62: 817-830, 1984.
4. Weinberg, R. A. Tumor suppressor genes. Science (Washington DC), 254: 1138-1146, 1991.
5. Levine, A. J., Momand, J., and Finlay, C A. The p53 tumor suppressor gene. Nature (Lond.), 351: 453-456, 1991.
6. Lane, D. P. p53 guardian of the genome. Nature (Lond.), 358: 15-16, 1992.
7. Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavaneee, W., and Vogelstien, B. Clonal expansion of p53 mutant cells is associated with brain tumor expansion. Nature (Lond.), 355: 846-847, 1992.
8. Iggo, R., Gatter, K., Barek, J., Lane, D , and Harns, A. L. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet, 335 675-679, 1990.
9. Hollstein, M. C., Metcalf, R. A., Welsh, A., Montesano, R., and Harris, C. C. Frequent mutation of the p53 gene in human esophageal cancer. Proc. Natl. Acad. Sci USA, 887: 9958-9961, 1990.
10. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A J., and Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63: 1129-1136, 1990.
11. zur Hausen, H. Viruses in human cancer. Science (Washington DC), 254: 1167-1173, 1991.
12. Brachman, D. G., Graves, D., Vokes, E., Beckett, M., Haraf, D., Montag, A., Dunphy, E., Mick, R., Yandell, D., and Weichselbaum, R. R. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res., 52: 4832-4836, 1992.
13. Boyle, J. O., Hakim, J., Koch, W., van der Riet, P., Hruban, R. H., Roa, R. A., Correo, R., Eby, Y. J., Ruppert, J. M., and Sidransky, D. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res., 53: 4477-4480, 1993.
14. Frank, J. L., Bur, M. E., Garb, J. L., Kay, S., Ware, J. L., Sismanis, A., and Neifeld, J. P. p53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx. Cancer (Phila.), 73: 181-186, 1994.
15. Clayman, G. L., Stewart, M. G., Weber, R. S., el-Naggar, A. K., and Grimm, E. A. Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Arch. Otolaryngol. Head & Neck Surg., 120: 743-748, 1994.
16. Snijders, P. J., Cromme, F. V., van den Brule, A. J., Schrijnemakers, H. F., Snow, G. B., Meijer, C. J., and Walboomers, J. M. Prevalence and expression of human papillomavirus in tonsilar carcinomas, indicating a possible viral etiology Int. J. Cancer, 51: 845-850, 1992.
17. Mullis, K. B., and Fallona, F. A. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol., 155: 335-350, 1987.
18. Orita, M., Suzuki, Y., Seikiya, T., and Hayashi, K. Rapid sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5: 874-879, 1989.
19. Sanger, F., Nicklen, S., and Coulson, A. R. DNA sequencing chain-terminating inhibitors Proc. Natl. Acad. Sci. USA. 74: 5463-5467, 1977.
20. McNicol, P. J., and Dodd, J. G. High prevalence of human papillomavirus in prostate tissue. J. Urol., 145: 850-853, 1991.
21. Ting, Y., and Manos, M. M. Detection and typing of genital human papilloma viruses. In: M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White (eds.), PCR Protocols: A Guide to Methods and Applications, pp 356-367. San Diego, CA: Academic Press, Inc., 1990.
22. Lungu, O., Wright, T. C., Jr., and Silverstein, S. Typing of human papillomaviruses by polymerase chain reaction amplification with LI consensus primers and RFLP analysis. Mol. Cell. Probes, 6, 145-152, 1992.
23. Snedecor, G. W , and Cochran, W G. Statistical Method, Ed. 7. Ames, IA: Iowa State University Press, 1980.
24. Armitage, P. Tests for linear trends in proportions and frequencies. Biometrics, 11: 375-386, 1955
25. Kaplan, E. L., and Meier, P Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
26. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163-170, 1966.
27. Cox, D R. Regression models and lifetables. J. Royal Stat. Soc., Series B, 34: 187-220, 1972.
28. Bishop, J. M. Molecular themes in oncogenesis. Cell, 64, 235-248, 1991.
29. Harris, C. C., and Hollstein, M. Clinical implications of the p53 tumor suppressor gene. N. Engl. J. Med., 329: 1318-1327, 1993.
30. Somers, K. D., Merrick, M. A., Lopez, M. E., Incognito, L. S., Schachter, G. L., and Carey, G. Frequent p53 mutations in head and neck cancer. Cancer Res., 52: 5997-6000, 1992.
31. Watling, D. L., Gown, A. M , and Coltera, M. D Over expression of p53 in head and neck cancer. Head & Neck, 14: 437-444, 1992.
32. Pavelic, Z. P., Gluckman, J. L., Gapany, M., Reising, J., Craven, J. M., Kelley, D J , Pavelic, L , Gapany, S., Biddinger, P., and Stambrook, P. J. Improved immunohistochemical detection of p53 protein in paraffin-embedded tissues reveals elevated levels in most head and neck and lung carcinomas: correlation with clinicopathological parameters. Anticancer Res., 12: 1389-1394, 1992.
33. Yin, X. Y., Smith, M. L., Whiteside, T. L., Johnson, J. T., Herberman, R B., and Locker, J. Abnormalities in the p53 gene in tumors and cell lines of human squamous cell carcinomas of the head and neck. Int. J. Cancer, 54: 322-327, 1993.
34. Field, J. K., Pavelic, Z. P., Spandidos, D. A., Stambrook, P. J., Jones, A. S., and Gluckman, J. L. the role of p53 rumor suppressor gene in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head & Neck Surg., 119: 1118-1122, 1993.
35. Scheffner, M., Munger, K., Byme, J. C., and Howley, P. M. The stage of p53 and the retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA, 88: 5523-5527, 1991.
36. Werness, B. A., Levine, A. J., and Howley, P. M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science (Washington DC), 248: 76-79, 1990.
37. Gissman, L., Diehl, V., Schultz-Caulton, H J., and zur Hausen, H. Molecular cloning and characterization of HPV from a laryngeal papilloma. J. Virol., 44: 393-400, 1982.
38. Steinberg, B. M. Role of human papillomaviruses in benign and malignant lesions. In: W. K. Hong and R. S. Weber (eds.), Head and Neck Cancer, pp 1-16. Boston: Klewer Academic Publishers, 1995.
39. Field, J. K., Spandidos, D. A., Malliri, A., Gosney, J. R., Yiagnisis, M., and Stell, P. M. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br. J. Cancer, 64: 573-577, 1991.
40. Field, J. K., Spandidos, D. A., and Stell, P M. Over expression of p53 gene in head and neck cancer, linked with heavy smoking and drinking. Lancet, 339: 502-503, 1992.
41. Riou, G., Favre, M., Jeanel, D., Bourhis, J., Le Doussal, V., and Orth, G. Association between poor prognosis in early stage invasive cervical carcinoma and non-detection of HPV DNA. Lancet, 355: 1171-1174, 1990.
42. Higgins, G. D., Davy, M., Rader, D., Uzelin, D. M., Phillips, G. E., and Burrell, C. J. Increased age and mortality associated with cervical carcinomas negative for human papilloma virus RNA. Lancet, 338: 910-913, 1991.
43. Brennan, J A., Mao, L., Hruban, R. H., Boyle, J. O., Eby, Y. J., Koch, W. M., Goodman, S. N., and Sidransky, D. Molecular assessment of histopathologic staging in squamous-cell carcinoma of the head and neck. N. Engl. J. Med , 332: 429-435, 1995.